IFNG and type 1 diabetes mellitus: Moreover, in vivo functionalized β-cells present both islet specific antigen and PD-L1 to participating T cells, reversing early-onset T1D by reducing IFN-γ-expressing cytotoxic T cells and inducing antigen-specific tolerance (68).